SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $341,000 | +54.3% | 12,477 | +109.3% | 0.00% | – |
| Q1 2023 | $221,000 | -16.0% | 5,962 | -17.6% | 0.00% | -100.0% |
| Q4 2022 | $263,000 | -78.4% | 7,232 | -85.9% | 0.00% | -85.7% |
| Q2 2020 | $1,217,000 | +499.5% | 51,379 | +1173.3% | 0.01% | +600.0% |
| Q3 2018 | $203,000 | -19.4% | 4,035 | -4.5% | 0.00% | -50.0% |
| Q2 2018 | $252,000 | -45.7% | 4,225 | -77.5% | 0.00% | -60.0% |
| Q3 2016 | $464,000 | +51.6% | 18,761 | -7.2% | 0.01% | +400.0% |
| Q1 2016 | $306,000 | +3.7% | 20,207 | -6.8% | 0.00% | -75.0% |
| Q4 2015 | $295,000 | – | 21,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |